Costs associated with Alzheimer's disease in Italy: baseline results from the GERAS II observational study

被引：0
|
作者：
Bruti, G. [1 ]
Bruno, G. [2 ]
Mancini, M. [1 ]
Reed, C. [3 ]
机构：
[1] Eli Lilly Italy, Global Patient Safety Neurosci, Florence, Italy
[2] Univ Rome, Dept Neurol & Psychiat, Rome, Italy
[3] Eli Lilly & Co Ltd, Global Patient Outcomes & Real World Evidence, Windlesham, Surrey, England
来源：
JOURNAL OF ALZHEIMERS DISEASE | 2016年 / 52卷
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：S61 / S62
页数：2
相关论文
共 50 条
  • [41] Response to "Factors associated with long-term impact on informal caregivers during Alzheimer's disease dementia progression: 36-month results from GERAS"
    Kajiwara, Kohei
    Kako, Jun
    Noto, Hiroko
    Oosono, Yasufumi
    Kobayashi, Masamitsu
    INTERNATIONAL PSYCHOGERIATRICS, 2020, 32 (02) : 279 - 280
  • [42] The incremental costs associated with behavioral symptoms in Alzheimer's disease
    Murman, DL
    Chen, Q
    Powell, MC
    Colenda, CC
    NEUROLOGY, 2001, 56 (08) : A160 - A161
  • [43] Institutionalization risk and costs associated with agitation in Alzheimer's disease
    Cloutier, Martin
    Gauthier-Loiselle, Marjolaine
    Gagnon-Sanschagrin, Patrick
    Guerin, Annie
    Hartry, Ann
    Baker, Ross A.
    Duffy, Ruth
    Gwin, Keva
    Aigbogun, Myrlene Sanon
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2019, 5 (01) : 851 - 861
  • [44] Baseline results of a virtual longitudinal, observational study of Parkinson's disease: The AT-HOME PD cohort
    Myers, T.
    Schneider, R.
    Omberg, L.
    Macklin, E.
    Baloga, E.
    Snyder, P.
    Duquette, S.
    Amodeo, K.
    Tarolli, C.
    Adams, J.
    Lungu, C.
    Gottesman, J.
    Kayson, E.
    Dorsey, E.
    Mangravite, L.
    Simuni, T.
    Schwarzschild, M.
    MOVEMENT DISORDERS, 2020, 35 : S408 - S409
  • [45] Cognition in MCI and Alzheimer's Disease: Baseline Data from a Longitudinal Study of the NTB
    Harrison, John
    Rentz, Dorene M.
    McLaughlin, Trent
    Niecko, Timothy
    Gregg, Keith M.
    Black, Ronald S.
    Buchanan, Jacqui
    Liu, Enchi
    Grundman, Michael
    CLINICAL NEUROPSYCHOLOGIST, 2014, 28 (02) : 252 - 268
  • [46] Baseline Results: The Association Between Cardiovascular Risk and Preclinical Alzheimer's Disease Pathology (ASCEND) Study
    Kumar, Veena V.
    Huang, Hanfeng
    Zhao, Liping
    Verble, Danielle D.
    Nutaitis, Alexandra
    Tharwani, Sonum D.
    Brown, Alexandra L.
    Zetterberg, Henrik
    Hu, William
    Shin, Ryan
    Kehoe, Patrick G.
    Quyyumi, Arshed
    Nocera, Joe
    Kippels, Andrea
    Wharton, Whitney
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 75 (01) : 109 - 117
  • [47] Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer's Disease in an Observational Cohort Study
    Morys, Filip
    Potvin, Olivier
    Zeighami, Yashar
    Vogel, Jacob
    Lamontagne-Caron, Remi
    Duchesne, Simon
    Dagher, Alain
    JOURNAL OF ALZHEIMERS DISEASE, 2023, 91 (03) : 1059 - 1071
  • [48] Costs of diagnosing early Alzheimer's disease in three European memory clinic settings: Results from the precision medicine in Alzheimer's disease project
    Wimo, Anders
    Kirsebom, Bjorn-Eivind
    Timon-Reina, Santiago
    Vromen, Ellen
    Selnes, Per
    Bon, Jaka
    Emersic, Andreja
    Kramberger, Milica Gregoric
    Speh, Andreja
    Visser, Pieter Jelle
    Winblad, Bengt
    Fladby, Tormod
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2024, 39 (07)
  • [49] Representativeness of European clinical trial populations in mild Alzheimer's disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
    Reed, Catherine
    Belger, Mark
    Dell'Agnello, Grazia
    Kahle-Wrobleski, Kristin
    Sethuraman, Gopalan
    Hake, Ann
    Raskin, Joel
    Henley, David
    ALZHEIMERS RESEARCH & THERAPY, 2018, 10
  • [50] Representativeness of European clinical trial populations in mild Alzheimer’s disease dementia: a comparison of 18-month outcomes with real-world data from the GERAS observational study
    Catherine Reed
    Mark Belger
    Grazia Dell’Agnello
    Kristin Kahle-Wrobleski
    Gopalan Sethuraman
    Ann Hake
    Joel Raskin
    David Henley
    Alzheimer's Research & Therapy, 10
12345